mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.2 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.008 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.004 |
0.9 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.5 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.0056 |
0.9 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.2 |